All Categories
Product description Chronic graft versus host disease (GVHD) is the most common complication of allogenic bone marrow transplantation. Because of the protracted clinical course of chronic GVHD, transplant centers and hematology/oncology offices are inadequately equipped to manage these immuno-incompetent patients with a multi-system disorder. Practitioners need to be able to recognize and effectively manage chronic GVHD as a late effect of more than half of allogenic transplantations. The text is oriented for the clinician, with chapters covering staging, organ site and system-specific manifestations, treatment options, and supportive care. Drs. Georgia B. Vogelsang and Steven Z. Pavletic have been pioneers in the recognition of the multi-organ complexity of this disease and have gathered the input of a variety of subspecialist physicians for this book. This book fills the gap in practical literature on chronic GVHD, providing a comprehensive, up-to-date, and clinically relevant resource for anyone who deals with cancer patients post-transplant. Review 'The editors, Drs Georgia B. Voselsang and Steven Z. Pavletic, pioneers in the recognition of the multi-organ complexity of this disease, have included in the writing of this book a refreshing variety of subspecialists... the very first textbook dedicated to the cGVHD. It is easy to predict that it will have [a] permanent place in medical history with [a] strong impact [on] future understanding of the disease. ... excellent book.' Croatian Medical Journal Book Description Chronic graft versus host disease (GVHD) is the most common complication of allogenic bone marrow transplantation, leading to immuno-incompetence and multi-system disorders in more than half of allogenic transplant patients. This book fills the gap in practical literature on chronic GVHD as a comprehensive, up-to-date, and clinically relevant resource, written for the clinician. About the Author Georgia B. Vogelsang, MD, is Professor of Oncology at the Johns Hopkins University School of Medicine, Baltimore, Maryland. Steven Z. Pavletic, MD, is the head of the Graft versus Host and Autoimmunity Unit in the Experimental Transplantation and Immunology Branch of the National Cancer Institute, Bethesda, Maryland.